# Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma

> **NCT03797170** · — · UNKNOWN · sponsor: **University of Bologna** · enrollment: 50 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **OTHER:** Gut microbiota samples

## Key facts

- **NCT ID:** NCT03797170
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-02
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-12-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03797170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03797170, "Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03797170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*